These results are in agreement with the findings of Malaguarnera et al. [28], who showed that HO-1 expression was significantly increased in NASH patients, and the increase reflected the severity of the disease. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatohepatitis.